Form 4: McKesson Corp Director, Bradley E. Lerman, Reports Acquisition of Restricted Stock Units

Director Bradley E. Lerman reports acquisition of 349 Restricted Stock Units (RSUs) in McKesson Corp on July 31, 2024, vesting immediately but with deferred share receipt.

Summary

• On July 31, 2024, Bradley E. Lerman, a director of McKesson Corp, acquired 349 Restricted Stock Units (RSUs).
• The RSUs were granted under the 2022 Stock Plan as part of an automatic annual grant.
• The grant vests immediately, but the underlying shares will be received when the director leaves the Board.
• Following the transaction, Lerman directly owns 349 shares of common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed neutrally. The grant of RSUs can be seen as a positive sign of aligning director interests with shareholder value.

Positives

• The grant of RSUs aligns the director's interests with the long-term performance of the company.
• The immediate vesting of the RSUs provides an incentive for continued service on the board.

Industry Context

This type of equity compensation is common for directors of publicly traded companies to align their interests with shareholders.

Comparison to Industry Standards

• Granting restricted stock units (RSUs) to board members is a common practice among publicly traded companies, including those in the healthcare sector like UnitedHealth Group (UNH) and CVS Health (CVS).
• The number of RSUs granted and the vesting schedule can vary based on company size, performance, and board compensation policies.
• Deferred delivery of shares until board departure is a less common but not unheard of practice, potentially aimed at ensuring long-term commitment and continuity.

Stakeholder Impact

• The grant of RSUs aligns the director's interests with those of the shareholders.
• Employees may view this as a positive sign of the company's commitment to its leadership.

Key Dates